{"entity":{"type":"insider","cik":"0001351187","url":"/insider/0001351187","json_url":"/insider/0001351187.json","name":"ACCIPITER LIFE SCIENCES FUND II L P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":166,"n_filings":28,"first":"2007-06-26","last":"2009-12-28","span_basis":"filed_date"},"name_variants":[{"name":"ACCIPITER LIFE SCIENCES FUND II L P","source":"filing","n_filings":28,"first_seen":"2007-06-26","last_seen":"2009-12-28"}],"transactions":[{"id":5882631,"accession":"0001193805-09-002575","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-09-002575","line_url":"/filing/0001193805-09-002575#line-3","is_derivative":false,"issuer_cik":"0001107216","issuer_name":"ORCHID CELLMARK INC","issuer_ticker":"ORCH","issuer_name_source":null,"issuer_url":"/issuer/0001107216","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; Candens Capital LLC; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND II L P; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER CAPITAL MANAGEMENT, LLC","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":724853.0,"shares_display":"724,853","price_per_share":1.5749,"price_display":"1.57","price_state":"stated","total_value":1141570.9897,"total_display":"1,141,570.99","total_whole":"1,141,571","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-23","filed_date":"2009-12-28","scope":"insider"},{"id":5882629,"accession":"0001193805-09-002575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-09-002575","line_url":"/filing/0001193805-09-002575","is_derivative":false,"issuer_cik":"0001107216","issuer_name":"ORCHID CELLMARK INC","issuer_ticker":"ORCH","issuer_name_source":null,"issuer_url":"/issuer/0001107216","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; Candens Capital LLC; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND II L P; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER CAPITAL MANAGEMENT, LLC","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1494432.0,"shares_display":"1,494,432","price_per_share":1.5848510125586175,"price_display":"1.58","price_state":"stated","total_value":2368452.0684,"total_display":"2,368,452.07","total_whole":"2,368,452","shares_owned_after":2342385.0,"shares_owned_after_display":"2,342,385","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-12-23","filed_date":"2009-12-28","scope":"insider","n_lines":2},{"id":3561248,"accession":"0000921895-08-003053","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000921895-08-003053","line_url":"/filing/0000921895-08-003053","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND LP; Candens Capital LLC; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD","owner_display_name":"ACCIPITER LIFE SCIENCES FUND II L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12900.0,"shares_display":"12,900","price_per_share":2.5125,"price_display":"2.51","price_state":"stated","total_value":32411.25,"total_display":"32,411.25","total_whole":"32,411","shares_owned_after":1098984.0,"shares_owned_after_display":"1,098,984","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-09","filed_date":"2008-12-10","scope":"insider","n_lines":2},{"id":3561246,"accession":"0000921895-08-003053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-08-003053","line_url":"/filing/0000921895-08-003053","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND LP; Candens Capital LLC; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD","owner_display_name":"ACCIPITER LIFE SCIENCES FUND II L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20200.0,"shares_display":"20,200","price_per_share":2.5057,"price_display":"2.51","price_state":"stated","total_value":50615.14,"total_display":"50,615.14","total_whole":"50,615","shares_owned_after":1130885.0,"shares_owned_after_display":"1,130,885","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-08","filed_date":"2008-12-10","scope":"insider","n_lines":2},{"id":2860187,"accession":"0000921895-08-002996","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-08-002996","line_url":"/filing/0000921895-08-002996","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER CAPITAL MANAGEMENT, LLC; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND LP; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; Candens Capital LLC; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE","owner_display_name":"ACCIPITER LIFE SCIENCES FUND II QP L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55000.0,"shares_display":"55,000","price_per_share":2.5015,"price_display":"2.50","price_state":"stated","total_value":137582.5,"total_display":"137,582.50","total_whole":"137,583","shares_owned_after":1120653.0,"shares_owned_after_display":"1,120,653","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-02","filed_date":"2008-12-04","scope":"insider","n_lines":2},{"id":3437015,"accession":"0000921895-08-002965","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000921895-08-002965","line_url":"/filing/0000921895-08-002965","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND LP; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND II QP L P; Candens Capital LLC","owner_display_name":"ACCIPITER LIFE SCIENCES FUND II L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45000.0,"shares_display":"45,000","price_per_share":2.5116,"price_display":"2.51","price_state":"stated","total_value":113022.0,"total_display":"113,022.00","total_whole":"113,022","shares_owned_after":1055142.0,"shares_owned_after_display":"1,055,142","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-01","filed_date":"2008-12-01","scope":"insider","n_lines":2},{"id":3437011,"accession":"0000921895-08-002965","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000921895-08-002965","line_url":"/filing/0000921895-08-002965#line-3","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND LP; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND II QP L P; Candens Capital LLC","owner_display_name":"ACCIPITER LIFE SCIENCES FUND II L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":2.5375,"price_display":"2.54","price_state":"stated","total_value":507.5,"total_display":"507.50","total_whole":"508","shares_owned_after":1069067.0,"shares_owned_after_display":"1,069,067","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-28","filed_date":"2008-12-01","scope":"insider"},{"id":3437009,"accession":"0000921895-08-002965","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-08-002965","line_url":"/filing/0000921895-08-002965","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND LP; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND II QP L P; Candens Capital LLC","owner_display_name":"ACCIPITER LIFE SCIENCES FUND II L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.5125,"price_display":"2.51","price_state":"stated","total_value":62812.5,"total_display":"62,812.50","total_whole":"62,813","shares_owned_after":1068867.0,"shares_owned_after_display":"1,068,867","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-26","filed_date":"2008-12-01","scope":"insider","n_lines":2},{"id":2435966,"accession":"0000921895-08-002941","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000921895-08-002941","line_url":"/filing/0000921895-08-002941","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; Candens Capital LLC; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; Accipiter Life Sciences Fund II Offshore Ltd","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":160000.0,"shares_display":"160,000","price_per_share":2.4821,"price_display":"2.48","price_state":"stated","total_value":397136.0,"total_display":"397,136.00","total_whole":"397,136","shares_owned_after":1056188.0,"shares_owned_after_display":"1,056,188","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-25","filed_date":"2008-11-25","scope":"insider","n_lines":2},{"id":2435957,"accession":"0000921895-08-002941","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000921895-08-002941","line_url":"/filing/0000921895-08-002941#line-9","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; Candens Capital LLC; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; Accipiter Life Sciences Fund II Offshore Ltd","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.5125,"price_display":"2.51","price_state":"stated","total_value":25125.0,"total_display":"25,125.00","total_whole":"25,125","shares_owned_after":974728.0,"shares_owned_after_display":"974,728","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-24","filed_date":"2008-11-25","scope":"insider"},{"id":2435953,"accession":"0000921895-08-002941","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000921895-08-002941","line_url":"/filing/0000921895-08-002941","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; Candens Capital LLC; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; Accipiter Life Sciences Fund II Offshore Ltd","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120640.0,"shares_display":"120,640","price_per_share":2.4898,"price_display":"2.49","price_state":"stated","total_value":300369.472,"total_display":"300,369.47","total_whole":"300,369","shares_owned_after":964728.0,"shares_owned_after_display":"964,728","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-21","filed_date":"2008-11-25","scope":"insider","n_lines":2},{"id":2435945,"accession":"0000921895-08-002941","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000921895-08-002941","line_url":"/filing/0000921895-08-002941","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; Candens Capital LLC; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; Accipiter Life Sciences Fund II Offshore Ltd","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":114900.0,"shares_display":"114,900","price_per_share":2.486,"price_display":"2.49","price_state":"stated","total_value":285641.4,"total_display":"285,641.40","total_whole":"285,641","shares_owned_after":903564.0,"shares_owned_after_display":"903,564","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-20","filed_date":"2008-11-25","scope":"insider","n_lines":2},{"id":2435937,"accession":"0000921895-08-002941","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000921895-08-002941","line_url":"/filing/0000921895-08-002941","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; Candens Capital LLC; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; Accipiter Life Sciences Fund II Offshore Ltd","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":74897.0,"shares_display":"74,897","price_per_share":2.4996,"price_display":"2.50","price_state":"stated","total_value":187212.5412,"total_display":"187,212.54","total_whole":"187,213","shares_owned_after":845441.0,"shares_owned_after_display":"845,441","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-19","filed_date":"2008-11-25","scope":"insider","n_lines":2},{"id":2435927,"accession":"0000921895-08-002941","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-08-002941","line_url":"/filing/0000921895-08-002941","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; Candens Capital LLC; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; Accipiter Life Sciences Fund II Offshore Ltd","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38700.0,"shares_display":"38,700","price_per_share":2.4541,"price_display":"2.45","price_state":"stated","total_value":94973.67,"total_display":"94,973.67","total_whole":"94,974","shares_owned_after":807007.0,"shares_owned_after_display":"807,007","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-18","filed_date":"2008-11-25","scope":"insider","n_lines":2},{"id":3236208,"accession":"0000921895-08-002862","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000921895-08-002862","line_url":"/filing/0000921895-08-002862","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; Candens Capital LLC; ACCIPITER LIFE SCIENCES FUND LP; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER CAPITAL MANAGEMENT, LLC","owner_display_name":"Accipiter Life Sciences Fund II Offshore Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29700.0,"shares_display":"29,700","price_per_share":2.4398,"price_display":"2.44","price_state":"stated","total_value":72462.06,"total_display":"72,462.06","total_whole":"72,462","shares_owned_after":770851.0,"shares_owned_after_display":"770,851","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-14","filed_date":"2008-11-14","scope":"insider","n_lines":2},{"id":3236197,"accession":"0000921895-08-002862","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-08-002862","line_url":"/filing/0000921895-08-002862","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; Candens Capital LLC; ACCIPITER LIFE SCIENCES FUND LP; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER CAPITAL MANAGEMENT, LLC","owner_display_name":"Accipiter Life Sciences Fund II Offshore Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":2.3677,"price_display":"2.37","price_state":"stated","total_value":71031.0,"total_display":"71,031.00","total_whole":"71,031","shares_owned_after":772490.0,"shares_owned_after_display":"772,490","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-12","filed_date":"2008-11-14","scope":"insider","n_lines":2},{"id":3117169,"accession":"0000921895-08-002860","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-08-002860","line_url":"/filing/0000921895-08-002860","is_derivative":false,"issuer_cik":"0001107216","issuer_name":"ORCHID CELLMARK INC","issuer_ticker":"ORCH","issuer_name_source":null,"issuer_url":"/issuer/0001107216","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER CAPITAL MANAGEMENT, LLC; Candens Capital LLC; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND II L P; ACCIPITER LIFE SCIENCES FUND LP; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD","owner_display_name":"ACCIPITER LIFE SCIENCES FUND II QP L P","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60200.0,"shares_display":"60,200","price_per_share":1.0338,"price_display":"1.03","price_state":"stated","total_value":62234.76,"total_display":"62,234.76","total_whole":"62,235","shares_owned_after":1199939.0,"shares_owned_after_display":"1,199,939","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-12","filed_date":"2008-11-14","scope":"insider","n_lines":2},{"id":2435783,"accession":"0000921895-08-002861","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-08-002861","line_url":"/filing/0000921895-08-002861","is_derivative":false,"issuer_cik":"0001171662","issuer_name":"TRIPLE-S MANAGEMENT CORP","issuer_ticker":"GTS","issuer_name_source":null,"issuer_url":"/issuer/0001171662","owner_cik":null,"owner_name":"Candens Capital LLC; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER CAPITAL MANAGEMENT, LLC; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND LP; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND II QP L P","owner_display_name":"Candens Capital LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Class B Common Stock, par value $1.00 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12812.0,"shares_display":"12,812","price_per_share":10.0707,"price_display":"10.07","price_state":"stated","total_value":129025.8084,"total_display":"129,025.81","total_whole":"129,026","shares_owned_after":475145.0,"shares_owned_after_display":"475,145","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-11-12","filed_date":"2008-11-14","scope":"insider","n_lines":2},{"id":3843645,"accession":"0000921895-08-002651","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000921895-08-002651","line_url":"/filing/0000921895-08-002651#line-7","is_derivative":false,"issuer_cik":"0001107216","issuer_name":"ORCHID CELLMARK INC","issuer_ticker":"ORCH","issuer_name_source":null,"issuer_url":"/issuer/0001107216","owner_cik":null,"owner_name":"Accipiter Life Sciences Fund II Offshore Ltd; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND II L P; Candens Capital LLC; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER LIFE SCIENCES FUND LP; ACCIPITER CAPITAL MANAGEMENT, LLC","owner_display_name":"Accipiter Life Sciences Fund II Offshore Ltd","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2100.0,"shares_display":"2,100","price_per_share":1.3458,"price_display":"1.35","price_state":"stated","total_value":2826.18,"total_display":"2,826.18","total_whole":"2,826","shares_owned_after":412354.0,"shares_owned_after_display":"412,354","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-24","filed_date":"2008-10-24","scope":"insider"},{"id":3398090,"accession":"0000921895-08-002675","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000921895-08-002675","line_url":"/filing/0000921895-08-002675","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; Candens Capital LLC; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND II QP L P; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER CAPITAL MANAGEMENT, LLC","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34100.0,"shares_display":"34,100","price_per_share":2.4414,"price_display":"2.44","price_state":"stated","total_value":83251.74,"total_display":"83,251.74","total_whole":"83,252","shares_owned_after":662924.0,"shares_owned_after_display":"662,924","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-24","filed_date":"2008-10-28","scope":"insider","n_lines":3},{"id":2435751,"accession":"0000921895-08-002650","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-08-002650","line_url":"/filing/0000921895-08-002650#line-2","is_derivative":false,"issuer_cik":"0001171662","issuer_name":"TRIPLE-S MANAGEMENT CORP","issuer_ticker":"GTS","issuer_name_source":null,"issuer_url":"/issuer/0001171662","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; ACCIPITER LIFE SCIENCES FUND II QP L P; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; Candens Capital LLC","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Class B Common Stock, par value $1.00 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12386.0,"shares_display":"12,386","price_per_share":12.2253,"price_display":"12.23","price_state":"stated","total_value":151422.5658,"total_display":"151,422.57","total_whole":"151,423","shares_owned_after":567451.0,"shares_owned_after_display":"567,451","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-23","filed_date":"2008-10-24","scope":"insider"},{"id":3843643,"accession":"0000921895-08-002651","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000921895-08-002651","line_url":"/filing/0000921895-08-002651#line-6","is_derivative":false,"issuer_cik":"0001107216","issuer_name":"ORCHID CELLMARK INC","issuer_ticker":"ORCH","issuer_name_source":null,"issuer_url":"/issuer/0001107216","owner_cik":null,"owner_name":"Accipiter Life Sciences Fund II Offshore Ltd; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND II L P; Candens Capital LLC; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER LIFE SCIENCES FUND LP; ACCIPITER CAPITAL MANAGEMENT, LLC","owner_display_name":"Accipiter Life Sciences Fund II Offshore Ltd","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3997.0,"shares_display":"3,997","price_per_share":1.4436,"price_display":"1.44","price_state":"stated","total_value":5770.0692,"total_display":"5,770.07","total_whole":"5,770","shares_owned_after":410254.0,"shares_owned_after_display":"410,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-22","filed_date":"2008-10-24","scope":"insider"},{"id":2435746,"accession":"0000921895-08-002650","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-08-002650","line_url":"/filing/0000921895-08-002650#line-1","is_derivative":false,"issuer_cik":"0001171662","issuer_name":"TRIPLE-S MANAGEMENT CORP","issuer_ticker":"GTS","issuer_name_source":null,"issuer_url":"/issuer/0001171662","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; ACCIPITER LIFE SCIENCES FUND II QP L P; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; Candens Capital LLC","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Class B Common Stock, par value $1.00 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25986.0,"shares_display":"25,986","price_per_share":12.2886,"price_display":"12.29","price_state":"stated","total_value":319331.5596,"total_display":"319,331.56","total_whole":"319,332","shares_owned_after":555065.0,"shares_owned_after_display":"555,065","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-22","filed_date":"2008-10-24","scope":"insider"},{"id":3561243,"accession":"0000921895-08-002624","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000921895-08-002624","line_url":"/filing/0000921895-08-002624","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND II QP L P; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; Candens Capital LLC","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":81793.0,"shares_display":"81,793","price_per_share":2.5052,"price_display":"2.51","price_state":"stated","total_value":204907.8236,"total_display":"204,907.82","total_whole":"204,908","shares_owned_after":645461.0,"shares_owned_after_display":"645,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-17","filed_date":"2008-10-17","scope":"insider","n_lines":2},{"id":3843641,"accession":"0000921895-08-002651","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000921895-08-002651","line_url":"/filing/0000921895-08-002651","is_derivative":false,"issuer_cik":"0001107216","issuer_name":"ORCHID CELLMARK INC","issuer_ticker":"ORCH","issuer_name_source":null,"issuer_url":"/issuer/0001107216","owner_cik":null,"owner_name":"Accipiter Life Sciences Fund II Offshore Ltd; HOFFMAN GABE; ACCIPITER LIFE SCIENCES FUND II L P; Candens Capital LLC; ACCIPITER LIFE SCIENCES FUND II QP L P; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER LIFE SCIENCES FUND LP; ACCIPITER CAPITAL MANAGEMENT, LLC","owner_display_name":"Accipiter Life Sciences Fund II Offshore Ltd","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":530342.0,"shares_display":"530,342","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":806119.84,"total_display":"806,119.84","total_whole":"806,120","shares_owned_after":797139.0,"shares_owned_after_display":"797,139","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-16","filed_date":"2008-10-24","scope":"insider","n_lines":5},{"id":3561241,"accession":"0000921895-08-002624","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000921895-08-002624","line_url":"/filing/0000921895-08-002624","is_derivative":false,"issuer_cik":"0001121439","issuer_name":"EMAGEON INC","issuer_ticker":"EMAG","issuer_name_source":null,"issuer_url":"/issuer/0001121439","owner_cik":null,"owner_name":"ACCIPITER LIFE SCIENCES FUND LP; ACCIPITER LIFE SCIENCES FUND OFFSHORE LTD; ACCIPITER CAPITAL MANAGEMENT, LLC; ACCIPITER LIFE SCIENCES FUND II QP L P; Accipiter Life Sciences Fund II Offshore Ltd; ACCIPITER LIFE SCIENCES FUND II L P; HOFFMAN GABE; Candens Capital LLC","owner_display_name":"ACCIPITER LIFE SCIENCES FUND LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.001 Par Value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":133700.0,"shares_display":"133,700","price_per_share":2.4831,"price_display":"2.48","price_state":"stated","total_value":331990.47,"total_display":"331,990.47","total_whole":"331,990","shares_owned_after":598065.0,"shares_owned_after_display":"598,065","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-10-16","filed_date":"2008-10-17","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":"2008-10-16|3561239","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001107216","name":"ORCHID CELLMARK INC","url":"/issuer/0001107216","role":"Other","n_filings":8,"first_seen":"2007-09-07","last_seen":"2009-12-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001121439","name":"EMAGEON INC","url":"/issuer/0001121439","role":"Ten percent owner","n_filings":9,"first_seen":"2008-02-14","last_seen":"2008-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001171662","name":"TRIPLE-S MANAGEMENT CORP","url":"/issuer/0001171662","role":"Ten percent owner","n_filings":3,"first_seen":"2008-10-14","last_seen":"2008-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0000906326","name":"RURAL/METRO CORP /DE/","url":"/issuer/0000906326","role":"Ten percent owner","n_filings":6,"first_seen":"2007-06-26","last_seen":"2008-03-18"},{"type":"issuer","type_label":"ISSUER","cik":"0000887497","name":"HI TECH PHARMACAL CO INC","url":"/issuer/0000887497","role":"Ten percent owner","n_filings":2,"first_seen":"2007-08-08","last_seen":"2008-03-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001351187","retrieved_at":"2026-08-23T14:13:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}